Results 111 to 120 of about 2,014 (147)

[Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lu JB, Cao L, Liu HL, Miao Y, Shen HR, Xia Y, Yin H, Cheng YX, Li JY, Fan L.   +9 more
europepmc   +1 more source

[Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced 
Non-small Cell Lung Cancer and Its Therapeutic Effect]. [PDF]

Zhongguo Fei Ai Za Zhi, 2021
Wang Y, Wang Y, Jiang M, Zhao Y, Zhang X.   +4 more
europepmc   +1 more source

[Analysis of antiviral efficacy in pediatric patients with HBeAg-negative chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Guo X, Fan PY, Li J, Wang LX, Dong Y, Cao LL, Yan JG, Zhang M, Wang FS.   +8 more
europepmc   +1 more source

[The role and mechanism of chemokine network in promoting osteoarthritis progression by regulating synovial macrophage heterogeneity]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Lin Y, Wu L, Chen Q, Shen B.
europepmc   +1 more source

[Contrast-enhanced CT-based habitat radiomics for analyzing the predictive capability for oral squamous cell carcinoma]. [PDF]

Hua Xi Kou Qiang Yi Xue Za Zhi
Liu Q, Liang Z, Yang S, Dong H.
europepmc   +1 more source

[Risk Factors, Molecular Mechanisms, and Multimodal Early Warning Strategies 
for Immune Checkpoint Inhibitor-associated Pneumonitis in Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhan J, Chen X, Li N.
europepmc   +1 more source

[IKZF3/Aiolos and tumors]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Jia Q, Shao K, Li Y, Mei Y, Zhang F.
europepmc   +1 more source

[Research Progress of Peripheral Immune Tolerance in Oral Diseases]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Wen K, Zhang P, Peng X.
europepmc   +1 more source

[Effects of PEG-IFN-α treatment on the expression of CD⁺161 and PD-1 in CD8⁺ T cells of patients with chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Li YP, Liu CR, Zhang X, Huang N, Zhang W, Yang L, Dang SS.   +6 more
europepmc   +1 more source

[The guideline for the diagnosis and treatment of marginal zone lymphoma in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Hematological Oncology Committee of China Anti-Cancer Association, Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association, Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO), Chinese Workshop of Indolent Lymphomas.   +5 more
europepmc   +1 more source